Sarcopenia Screening in Elderly Individuals
1 other identifier
interventional
843
0 countries
N/A
Brief Summary
In this study, it is aimed to evaluate parameters such as sarcopenia screening, muscle mass measurement, loss of strength that may develop due to sarcopenia, loss of balance and related fall, decrease in functionality, fragility and decreased physical activity in individuals aged 65 years and older in Kırıkkale city center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedAugust 25, 2023
August 1, 2023
1 month
August 20, 2023
August 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bioimpedance Analysis
used to measure muscle mass in epidemiological studies.A muscle mass index of less than 5.5 in women and less than 7 in men is associated with the risk of sarcopenia.
day 1
Secondary Outcomes (8)
Muscle Strength Evaluation
day 1
Short Physical Performance Test
day 1
SARC-F
day 1
Mini Nutritional Assessment
day 1
Physical Activity Scale for the Elderly
day 1
- +3 more secondary outcomes
Study Arms (1)
Individuals aged 65 and over who were screened for sarcopenia
OTHERPersons aged 65 and over will be evaluated only once and the assessment will be made through a face-to-face interview.
Interventions
Elderly individuals will be evaluated once, by face-to-face interview method.
Eligibility Criteria
You may qualify if:
- Individuals aged 65 and over
- Their willingness to participate in the study
- A score of 24 or higher on the Mini Mental State Test (MMDT)
You may not qualify if:
- Individuals under the age of 65
- Individuals who cannot communicate well
- Elderly individuals who cannot walk independently, have any orthopedic or neurological problems
- Individuals who do not want to participate in the study
- Individuals not eligible for bioimpedance analysis (pregnant individuals with pacemakers).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master of Science Student
Study Record Dates
First Submitted
August 20, 2023
First Posted
August 25, 2023
Study Start
September 1, 2023
Primary Completion
October 1, 2023
Study Completion
January 1, 2024
Last Updated
August 25, 2023
Record last verified: 2023-08